Each block closure is expected to last approximately a week, putting the final completion date around late November, pending any potential weather delays.
These infusion centers, equipped with Regeneron's monoclonal antibodies, will treat COVID-19 patients who do not need hospitalization with therapeutic drugs that can prevent their condition from worsening and requiring hospital care.